ImmunityBio Shares Are Trading Higher on Continued Strength After the Company on Thursday Announced Insurance Coverage of ANKTIVA Across Multiple States With First Commercial Doses Administered.
ImmunityBio Shares Are Trading Higher on Continued Strength After the Company on Thursday Announced Insurance Coverage of ANKTIVA Across Multiple States With First Commercial Doses Administered.
保险业中免疫生物股份正在继续增强，周四宣布在多个州提供ANKTIVA的保险覆盖后，首次商业剂量已经投放。
ImmunityBio Shares Are Trading Higher on Continued Strength After the Company on Thursday Announced Insurance Coverage of ANKTIVA Across Multiple States With First Commercial Doses Administered.
保险业中免疫生物股份正在继续增强，周四宣布在多个州提供ANKTIVA的保险覆盖后，首次商业剂量已经投放。